Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Melanoma 2Rhabdomyosarcoma 1

Interventions

Nivolumab 3fludarabine 2Ipilimumab 2tipifarnib 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1pembrolizumab 1iso-sulfan blue 1fludarabine phosphate 1dostarlimab 1bempegaldesleukin 1Stem Cell Transplantation 1Sirolimus 1Mesna 1Melphalan 1Mass Spectrometry 1LY2940680 1Immunologic Techniques 1Cyclophosphamide 1Cryotherapy 1Cryosurgery 1Chromatography, High Pressure Liquid 1CTLA-4 Antigen 1Busulfan 1BI 2536 1Alemtuzumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × iso-sulfan blue × Dermatologic × Clear all
NCT02509598 2024-06-28

A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping

Cardinal Health 414, LLC

Phase 2 Completed
24 enrolled 18 charts
DermatologicSarcoma

Melanoma, Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡